Rare diseases
Investigational molecules
Locations
Back to Slovakia16 clinical trials in Sahy, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
SlovakiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SlovakiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
SlovakiaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
SlovakiaStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
SlovakiaStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
SlovakiaSlovakiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
SlovakiaStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
SlovakiaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
SlovakiaStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
SlovakiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on ulcerative colitis are evaluating new therapeutic approaches for patients with moderate to severe forms of the condition. These studies aim to assess different medications' effectiveness in achieving clinical remission and improving patient outcomes.
Several innovative compounds including BI 3032950, TAK-279, and mirikizumab are being studied for their potential benefits.
Research is underway examining treatments for deep vein thrombosis, specifically focusing on clot dissolution in proximal DVT. These trials are evaluating both the effectiveness and safety profiles of new therapeutic agents.
Current studies are investigating novel compounds like BAY 3018250 for improving outcomes in vascular conditions.
Clinical research is examining new treatments for celiac disease, particularly focusing on non-responsive cases. Studies are evaluating medications that may help patients better manage their condition while maintaining a gluten-free diet.
Innovative therapies like amlitelimab are being tested to address challenges in treatment-resistant cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
